Concord Biotech Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 287.74 | 260.41 | 217.67 | 439.27 | 258.95 |
| Other Income Qtr Cr | 9.98 | 13.35 | 13.68 | 9.38 | 14.73 |
| Operating Revenues Qtr | 277.77 | 247.06 | 203.99 | 429.88 | 244.22 |
Loading chart... | |||||
Operating Expenses Qtr | 178.79 | 158.57 | 142.59 | 239.46 | 146.27 |
Operating Profit Qtr | 98.98 | 88.49 | 61.40 | 190.42 | 97.95 |
EBITDA Qtr Cr | 105.68 | 101.84 | 75.07 | 199.81 | 112.68 |
Depreciation Qtr | 18.75 | 18.39 | 17.78 | 14.62 | 13.26 |
Net Profit Qtr | 64.48 | 63.58 | 44.06 | 140.39 | 75.92 |
Basic EPS Qtr | 6.08 | 6.03 | 4.21 | 13.42 | 7.26 |
Open Demat Account